AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7926494
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily
Trial: 8222667
Drug: Antihypertensive drug
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drug treatment
Trial: 23591549
Drug: Bilateral ultrasound-guided
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ultrasound-guided subcostal TAP block injections after induction of general anesthesia
Trial: 3520389
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous insulin infusion with micropump CPI 9100 Lilly
Trial: 29481979
Drug: 18 sessions
RxNorm normalized name: Alpinia Sessilis Root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 sessions of spinal manipulative therapy (SMT)
Trial: 23183149
Drug: Oral fluid
RxNorm normalized name: cascara sagrada ORAL FLUID EXTRACT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluid rapid HIV testing
Trial: 9868662
Drug: Ceftriaxone 2
RxNorm normalized name: ceftriaxone 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 2 g plus gentamicin 3 mg/kg once daily for 2 weeks
Trial: 15370581
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment, daily subcutaneous injections for 4 weeks
Trial: 16797329
Drug: Alendronate treatment
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate treatment
Trial: 26366481
Drug: Levothyroxine (LT4)
RxNorm normalized name: LT4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (LT4) treatment
Trial: 7751690
Drug: Alternating zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alternating zidovudine and didanosine therapy
Trial: 21844495
Drug: Carboplatin plus
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin plus paclitaxel 175 mg/m²
Trial: 11874940
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg pioglitazone
Trial: 8411145
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2.4 g long‐chain n‐3 fatty acids/day) for 4 weeks
Trial: 18279551
Drug: Beta-carotene supplementation
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene supplementation (20 mg/d)
Trial: 25894865
Drug: Selenomethionine (SeMet)
RxNorm normalized name: selenomethionine
DrugBank: Selenomethionine (DB11142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selenomethionine (SeMet) 200 μg daily (n = 28)
Trial: 19646212
Drug: MSP3-LSP candidate
RxNorm normalized name: LSP-GR3
DrugBank: LSP-GR3 (DB16934)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSP3-LSP candidate vaccine
Trial: 19646212
Drug: Tetanus toxoid
RxNorm normalized name: Tetanus Toxoid
DrugBank: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus toxoid vaccine (Control)
Trial: 8787251
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion during CPB
Trial: 25169846
Drug: Clarithromycin plus
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin plus neuraminidase inhibitors
Trial: 16037127
Drug: Water drink
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL SOLUTION [MAGIC WATER DRINKS, LLC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water drink (7.5 ml/kg body wt)
Trial: 1630666
Drug: Bezafibrate 400
RxNorm normalized name: bezafibrate 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate 400 mg daily
Trial: 10509550
Drug: Felodipine-metoprolol combination
RxNorm normalized name: felodipine / metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine-metoprolol combination tablet (Logimax)
Trial: 25370206
Drug: 20-mg tadalafil
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg tadalafil
Trial: 20156156
Drug: Second- and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second- and third-line antituberculosis agents
Trial: 16180526
Drug: Psychodynamic short-term
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychodynamic short-term psychotherapy (PSTP), 25 therapy sessions
Trial: 24576886
Drug: Antimicrobial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial therapy only (Control group)
Trial: 2233904
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving the same vaccine at the age of 24 months
Trial: 23718078
Drug: Combined application
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined application of gas-air carbonate baths and lysozyme inhalation
Trial: 7667826
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg protamine/100 U UFH
Trial: 7667826
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg protamine/100 anti‐Xa U LMWH
Trial: 21351838
Drug: Controlled-release vaginal
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release vaginal dinoprostone pessary
Trial: 12813199
Drug: Diuretic renogram
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic renogram with furosemide after vigorous intravenous hydration
Trial: 9264050
Drug: Estazolam drops
RxNorm normalized name: Estazolam
DrugBank: Estazolam (DB01215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estazolam drops (test formulation)
Trial: 6969194
Drug: tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiaprofenic acid 200 mg t.d.s.
Trial: 6793053
Drug: Halothane or
RxNorm normalized name: Halothane
DrugBank: Halothane (DB01159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halothane or morphine plus nitrous oxide
Trial: 18202320
Drug: FIR therapy
RxNorm normalized name: Douglas fir pollen extract
DrugBank: Pseudotsuga menziesii pollen (DB10986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FIR therapy in patients undergoing hemodialysis
Trial: 11874940
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg pioglitazone
Trial: 28591082
Drug: SoluMatrix indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SoluMatrix indomethacin 40 mg twice daily
Trial: 30155761
Drug: Betalain-rich beetroot
RxNorm normalized name: Maltose-rich malted barley extract
DrugBank: Barley malt syrup (DB14601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betalain-rich beetroot concentrate (BLN) 100 mg/day
Trial: 25493942
Drug: MNP -
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MNP - Fe (5 mg zinc)
Trial: 22970149
Drug: 600 mg/day
RxNorm normalized name: Rebetron, single dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg/day DHA (from algal oil)
Trial: 31154289
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (Etanercept + Methotrexate)
Trial: 18991147
Drug: Low-dose doxycycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose doxycycline in a hydrogel
Trial: 23355361
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of ranolazine 1,500 mg
Trial: 11911409
Drug: Cytosine arabinoside
RxNorm normalized name: Cytosine arabinoside
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cytosine arabinoside (ara-C) dose escalation to 15 and 20 mg/m2/d for 1-10 days
Trial: 9840848
Drug: Ropivacaine at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine at 8 mL/hour
Trial: 2124243
Drug: Interferon gamma
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon gamma (100 micrograms per subcutaneous injection, daily for the first 2 weeks, then 3 times per week)
Trial: 2124243
Drug: Interferon gamma
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon gamma (100 micrograms per subcutaneous injection)
Trial: 12087008
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg t.i.d.
Trial: 23524622
Drug: Papaya preparation
RxNorm normalized name: Carica papaya preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Papaya preparation (Caricol®)
Trial: 9803047
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) oxycodone 30 mg every 12 hr
Trial: 20032170
Drug: Home blood
RxNorm normalized name: LifeSource Aneroid Home Blood Pressure Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home blood pressure monitoring (at least weekly measurements)
Trial: 21149498
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) monotherapy, 20 mg/weekly
Trial: 31620931
Drug: Pertuzumab plus
RxNorm normalized name: Pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pertuzumab plus trastuzumab and chemotherapy
Trial: 1563884
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (10 capsules, 3 g per day, containing 1.8 g eicosapentaenoic acid and 1.2 g docosahexaenoic acid)
Trial: 22612765
Drug: Individually tailored
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually tailored oral health educational programme (ITOHEP) based on cognitive behavioural strategies
Trial: 11305263
Drug: High-phosphorus diet
RxNorm normalized name: Phosphorus
DrugBank: Phosphorus (DB14151)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-phosphorus diet (3008 mg P and 1995 mg Ca/day for 6 weeks)
Trial: 9072602
Drug: 280 mg
RxNorm normalized name: levodopa 280 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 280 mg estramustine phosphate 2 times daily
Trial: 9776856
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with beta-hydroxybutyrate on uninjured normal cells
Trial: 16309958
Drug: Ramelteon 4
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 4 mg
Trial: 18565860
Drug: Dronedarone 400
RxNorm normalized name: dronedarone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone 400 mg twice a day
Trial: 3055874
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg mifentidine
Trial: 24717710
Drug: Traditional injection
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional injection without the aid of the DentalVibe
Trial: 1562332
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups administered 4 ml of 4% lidocaine translaryngeally
Trial: 7734367
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg cladribine/m2/d
Trial: 30219436
Drug: Ginkgo Leaf
RxNorm normalized name: Ginkgo leaf
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo Leaf Tablets and Liuwei Dihuang Pills
Trial: 26059745
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of extracts from grape seed and skin, green tea, resveratrol, quercetin, ginkgo biloba and bilberry
Trial: 26206652
Drug: Goal-Directed Therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-Directed Therapy (GDT) using stroke volume variation
Trial: 11878524
Drug: Ropivacaine 2.5
RxNorm normalized name: fentanyl-ropivacaine 2.5 mcg/mL-0.1%-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2.5 mg with fentanyl 0.025 mg
Trial: 11878524
Drug: Bupivacaine 2.5
RxNorm normalized name: Sure-Amp BUPivacaine 2.5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2.5 mg with fentanyl 0.025 mg
Trial: 30630792
Drug: Pure topical
RxNorm normalized name: Clarifoam Pure Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure topical therapy of hydroquinone ointment
Trial: 2959439
Drug: Guar granules
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar granules (5 g) sprinkled over food for 4 weeks
Trial: 22334123
Drug: Intravenous nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nicotine (0.5 and 1.0 mg/70 kg)
Trial: 7859936
Drug: Low-dose bedtime
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose bedtime insulin/daytime sulfonylurea (BI-DSU)
Trial: 18539340
Drug: RUL ECT
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RUL ECT at a fixed dose of 403 mC
Trial: 17950161
Drug: Drug and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug and Alcohol Testing (DAT)
Trial: 15574078
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of beta-hydroxy beta-methylbutyrate (HMB) per day
Trial: 2828412
Drug: 1,25-dihydroxyvitamin D
RxNorm normalized name: 1,25-dihydroxyvitamin D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-dihydroxyvitamin D (1 microgram daily) in a hypoparathyroid patient
Trial: 31541942
Drug: Chlorogenic acid
RxNorm normalized name: chlorogenic acid
DrugBank: Chlorogenic Acid (DB12029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorogenic acid for injection (CAFI) administered intramuscularly
Trial: 26957044
Drug: Indoor residual
RxNorm normalized name: Cleartime Indoor & Outdoor Allergies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoor residual spraying and long-lasting insecticidal nets (not specified dosage or duration)
Trial: 20829069
Drug: Levosimendan at
RxNorm normalized name: levosimendan
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan at 0.05 μg/kg/min
Trial: 15487806
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (ASC) 0.48 g, 3 times daily for 6 days
Trial: 15487806
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ASA and ASC
Trial: 15957569
Drug: MEMS feedback
RxNorm normalized name: MEM 1003
DrugBank: MEM 1003 (DB05547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEMS feedback group (bupropion‐SR 150 mg)
Trial: 15962644
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine 300 microg (n = 25)
Trial: 8110249
Drug: 16-hour transdermal
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 16-hour transdermal nicotine patch
Trial: 894647
Drug: Monistat cream
RxNorm normalized name: Monistat
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Monistat cream (miconazole nitrate 2%) for 7 days
Trial: 10495460
Drug: Immediate zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate zidovudine treatment
Trial: 7997375
Drug: D2 receptor
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D2 receptor scintigraphy (123I-IBZM)
Trial: 23907785
Drug: Acoustic Coordinated
RxNorm normalized name: aconite
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acoustic Coordinated Reset (CR) neuromodulation therapy
Trial: 1618212
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (50 mg patch, 10 mg.24 h-1)
Trial: 26482244
Drug: Onion skin
RxNorm normalized name: ONION
DrugBank: Onion (DB10548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onion skin extract powder (approximately 163 mg quercetin)
Trial: 10886122
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of lefradafiban
Trial: 10886122
Drug: Jejunal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Jejunal administration of lefradafiban
Trial: 10886122
Drug: Ileal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ileal administration of lefradafiban
Trial: 31139877
Drug: CYP inducers
RxNorm normalized name: CYP-001
DrugBank: CYP-001 (DB15739)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYP inducers (concurrent medication)
Trial: 28699499
Drug: Argan oil
RxNorm normalized name: ARGAN OIL
DrugBank: Argan oil (DB14310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argan oil (30 ml per day for 8 weeks)
Trial: 17053334
Drug: Psychodynamic inpatient
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychodynamic inpatient treatment (n = 137)
Trial: 30572160
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) thrice weekly for 3–5 weeks
Trial: 10516931
Drug: Levofloxacin twice-a-day
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin twice-a-day therapy (200 mg/day for 7 days)
Trial: 10516931
Drug: Levofloxacin once-a-day
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin once-a-day therapy (200 mg/day for 7 days)
Trial: 2865177
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of antichlamydial antibodies
Trial: 23537967
Drug: Ticagrelor 90
RxNorm normalized name: ticagrelor 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor 90 mg twice daily for 30 days (for all patients)
Trial: 19931204
Drug: 24 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 24 weeks PEG-IFN alpha and ribavirin treatment
Trial: 1974399
Drug: Loratadine 20
RxNorm normalized name: Loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loratadine 20 mg
Trial: 19320851
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 375 μg
Trial: 22064208
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) at doses of 0.44, 1.3, or 2.7 g/d
Trial: 14602781
Drug: 300 microg
RxNorm normalized name: Voglibose 300 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 microg E2 combined with oral dydrogesterone (20 mg/d) during the last 14 days
Trial: 11803348
Drug: rabbit antithymocyte
RxNorm normalized name: Rabbit antithymocyte globulin
DrugBank: Antithymocyte immunoglobulin (rabbit) (DB00098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabbit antithymocyte globulin (ATG) 1.25 mg/kg on alternate days, starting at a median interval of 11 days after BMT
Trial: 14710104
Drug: Prenatal vitamin
RxNorm normalized name: Prenatal Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal vitamin with 400 IU of vitamin E and 500 mg of vitamin C
Trial: 15899030
Drug: Infliximab therapy
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab therapy (discontinued after 3 years)